ARCHIVES

Sunitinib Prolongs Survival In Poor Prognosis, Study Finds

This article is from The Cancer Letter archive.

Vol. 32 No. 7 | July 31, 2009

Download PDF Visit The Full Archive

Related Articles

DCT Issues Two Pas for Small/Exploratory Grants For Clinical, Laboratory Studies

March 23, 1994

Five-Year Course of Tamoxifen Remains Standard Treatment In HR+ Breast Cancer

July 26, 2002

PA Available

September 12, 1997

ASA Honors Bernard Fisher With Surgeons’ Highest Award.

April 21, 2000

Also R01 payline likely to fall below 20th percentile in FY04.

September 26, 2003

Stand Up To Cancer Selects Five Groups For “Dream Team” Grants Totaling $73.6M.

May 29, 2009